Raising awareness of the opportunities is emerging markets, in particular Africa to offer to the world (to patients, regulators, the pharmaceutical industry). This opportunity can only be realized succeed by building a team of Experts, Partners and Stakeholders who share a vision and passion for what we do. Our team come with solid experience and background in the pharmaceutical and Healthcare sector. The combined experience across understanding the science of the human body, technology innovations, the challenges faced today and the needs of patients who do not have a voice, speaks to our credibility and delivery mind-set.

Adama Ibrahim, EMBA
Founder and Chair
Adama is an innovation, multi award-winning Clinical Operations and Consulting Expert with extensive experience and skills gained from international global assignments.

A blockchain advocate and patient engagement thought leader with over 17 years in the NHS on commission by the DOH and in Industry (Hoffman La-Roche, Amgen, ALMAC, ICON and Biogen). An R&D transformation change champion and DIA Patient Engagement Voluntary Community Leadership. Far-reaching and varied knowledge across a broad range of Phase I, II, III and IV trials including Immunology, Neurology, IBD, Rare Disease and Gene Therapy. Experience across creation and execution of successful strategies for trials protocols and CRO oversight, patient and site feasibility, technologies such as eCOA and IVRS, optimal drug packaging and administration concepts, mapping the patient journey, planning and executing effective global site and patient engagement campaigns using direct to patient methods, leading and coaching remote and complex global teams.

Dr Peter Owotoki, MBA (PhD in Artificial Intelligence)
Chief Innovation Officer
Peter has a deep knowledge of AI and broad experience in Life Science and Pharma. He comes with strong expertise in value-driven digital transformations and restructuring programs at top global Pharma companies.
Peter has recently been an advanced analytics setup Lead at a top five Global Pharma company to develop the AI strategy and operating model to enable the organization's transformation into the global leading life science, medicines & data+digital player. He advises teams of senior executives to develop and execute major technological and operational transformations with measurable positive impact on combined spend of over 50billion USD in the past 5 years. He has been involved in the development of go-to-market strategy for major Pharma players focused on Sub Saharan Anglophone and Lusophone markets; and on strategy targetting hospital chains in Europe, Middle East, and Latin America. A former McKinsey consultant he is experienced with understanding and balancing the needs of decisions makers with those of other key stakeholders. He is passionate about technology having obtained a PhD in AI from Hamburg and following up with Post Doctoral research work at Harvard all before AI became so cool. A native of Nigeria and a German citizen, Peter is a strong believer in the power of building bridges across communities to solve seemingly intractable problems impacting on the greater good.
Nancy Meyerson-Hess, MPHIL
Chief Quality Assurance and Compliance Officer

Nancy Meyerson-Hess has over 30 years of experience in leading global clinical trials teams in pharmaceutical and contract trials organizations.

She has focused on providing best practices for success in global clinical trials, including emerging regions, in areas such as Good Clinical Practice and Inspection Readiness. In addition, she has extensive experience in patient-centered activities and solutions. Nancy is currently an Associate Partner at admedicum Business for Patients and is also a consultant in clinical trials with a focus on clinical trials and outsourcing through quality and process improvement.

David Lloyd
Chief Financial Officer

Experienced in the finance and banking sectors, David’s experience spams across multiple industries (Automobile Banking and Healthcare).

He has focused on the management of company finances, planning, financial risk assessments and reporting. David Lloyd has a Business Management degree and is a Qualified Coach, Physiotherapist, Counselor and Hypnotherapist with experience in Time Line Therapy and Neuro-Linguistic Programming.

Dr. Tina Barton
Chief Operating Officer

With over 40 years’ experience in clinical and drug development arena, Dr. Tina Barton has held a Board level role at the Institute of Clinical Research for 7 years (Chair for 2 years).

She held VP and Senior VP positions within Contract Research Organisations (PRA International, Covance and INC Research). She has worked with major Pharma companies and handled some of the largest accounts in business development, clinical operations and data management. Dr. Barton bring a wealth of experience from strategic business acumen, change management and process enhancement with a proven track record in driving growth and training for the future.

Shalom Lloyd
Chief Strategy Officer

With a BSc and MSc Pharm from the Ukrainian Academy of Pharmacy and an MBA from the University of Liverpool, Shalom has over 20 years experience in the Pharmaceutical and CRO Industry.

Making a difference to the lives of patients in emerging markets (particularly Africa) by championing the provision of targeted innovative medicines aimed at the needs of individuals is a true passion. She works with teams across all levels to develop strategies and operating models. With the belief that ‘There is Science and Technology in everything we do’, She is an award winning STEM Ambassador focused of strategy, leadership and connecting with the right people to the right opportunities, doing this by continuously challenging the status quo, with integrity, passion and fairness.

Bunmi Ipaye
Events Director

Bunmi has 17 years’ experience in sales and account management and enjoys working with the public interacting with a wide range of people.

Client interactions include universities, law and corporate firms as well as local government and charities. Expertise in sales of combined print and online advertising packages and corporate branding. She has represented the Law Society at various events and exhibitions both regionally and nationally. Technology expert in the use of CRM systems for data and market analysis to maximize customer experience and relationships.

Our stakeholders

Strategic Partners & Advisors

Sachin Sharma

(MOB, KP-Morgan)

Nigeria Patient Advocacy
Mrs Badiya Magaji Inuwa

(Sickle Cell Patient Health Promotion Center)

Nigeria CRO
Dr Ado Muhammed

(CEO, Pharmedas)

USA Investigator
Folakemi G Odedina

Professor, University of Florida
(Principal Investigator, Prostate Cancer Transatlantic Consortium)

Nigeria Pharmaceutical Society
Pharmacist Ahmed I Yakasai FPSN

(President of the Pharmaceutical Society)

Nigerian Clinical Trials Expert and Chair Association for Good Clinical Practice in Nigeria (AGCPN)
Ifeoma Okoye


Disa Lee Choun

(Head of Data Acquisition, UCB)